Status and phase
Conditions
Treatments
About
Phase 1, open-label, absorption, metabolism, excretion, and mass balance study.
Full description
A study of RPT193 in healthy volunteers to evaluate the route(s) of elimination and overall mass balance of RPT193 in urine and feces
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Is mentally or legally incapacitated or has significant emotional problems at the time of the screening visit
History or presence of clinically significant medical or psychiatric condition or disease
History or presence of alcohol or drug abuse within the past 2 years prior to dosing
History or presence of:
Positive for human immunodeficiency virus, hepatitis B, hepatitis C
Unwilling to abstain from alcohol, xanthane-containing beverages or food or foods containing grapefruit/Seville orange prior to admission
Received radiolabeled substances or exposed to radiation sources over past 12 months
Primary purpose
Allocation
Interventional model
Masking
7 participants in 1 patient group
Loading...
Central trial contact
Vice President, Clinical Development
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal